24 participants
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-13
- Start Date:
- 2025-06-24
- Completion:
- 2029-09-30
Conditions
- Recurrent Triple-Negative Breast Cancer
Interventions
- DRUG
No Results Yet